Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-23-006927

Options or other derivatives

  • Chief Accounting Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Burgess Julie · Chief Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-01 Grant or award : show line 1 in the form Stock Option (right to buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…